Prerecorded Webinar: Erectile Dysfunction Management

Pharmacist CEU
notesPre-Recorded
Contact Hours: 1.0 (0.1 CEUs)

Course Summary

Erectile dysfunction (ED) is the inability to maintain or achieve an erection satisfactory for intercourse. It is the most common cause of sexual dysfunction among men in the United States. An estimated 50% of men will experience some form of ED their lifetime, making this a significant medical problem. Despite a growing social awareness and acceptance of this disorder, many men remain hesitant to discuss issues related to ED with their partners and healthcare providers. Further, ED is too frequently not prioritized over other health issues. This is concerning from a public health perspective, given ED often results from serious underlying conditions, including metabolic syndrome and cardiovascular disease.


Course Objectives

Describe the prevalence and underlying causes of erectile dysfunction

Compare and contrast phosphodiesterase-5 inhibitors

Recall indications, contraindications, side effect profiles, and monitoring parameters for erectile dysfunction treatments


I. Introduction

II. Erectile Dysfunction: An Overview

III. Etiology

IV. Erectile Dysfunction Pathophysiology

V. Diagnosing Erectile Dysfunction

VI. Treating Erectile Dysfunction

VII. Phosphodiesterase-5 Inhibitors

1. Mechanism of Action and Pharmacokinetics
2. Renal and Hepatic Dosing Considerations
3. Geriatric Dosing Considerations
4. Adverse Effects
5. Drug and Food Interactions
6. Patient Monitoring
7. PDE5i Efficacy
8. Counseling

VIII. Prostaglandin E1

1. Mechanism of Action and Dosing
2. Adverse Reactions
3. Patient Monitoring
4. Alprostadil Efficacy

IX. Testosterone

1. Dosing and Administration
2. Patient Counseling

X. The Role of the Pharmacist

How to Earn Credit:
To earn credit for this course, participants must:
  1. Read the course objectives and faculty planner disclosure
  2. Read the course material
  3. Complete the post-test with a minimum score of 70% and complete the course evaluation form.
  4. Results are automatically submitted to CPE Monitor

Faculty Planner Disclosure

The following individuals were involved in the development of this activity: L. Austin Fredrickson, MD, FACP, and Susan DePasquale, MSN, PMHNP-BC. There are no financial relationships relevant to this activity to report or disclose by any of the individuals involved in the development of this activity.


Unlabeled Use Disclosures

The information provided in this course is general in nature and it is solely designed to provide participants with continuing education credit(s). This course and materials are not meant to substitute for the independent, professional judgment of any participant regarding that participant’s professional practice, including but not limited to patient assessment, diagnosis, treatment and/or health management. Medical and pharmacy practices, rules, and laws vary from state to state, and this course does not cover the laws of each state; therefore, participants must consult the laws of their state as they relate to their professional practice. Healthcare professionals, including pharmacists and pharmacy technicians, must consult with their employer, healthcare facility, hospital, or other organization, for guidelines, protocols, and procedures they are to follow. The information provided in this course does not replace those guidelines, protocols, and procedures but is for academic purposes only, and this course’s limited purpose is for the completion of continuing education credits. Participants are advised and acknowledge that information related to medications, their administration, dosing, contraindications, adverse reactions, interactions, warnings, precautions, or accepted uses are constantly changing, and any person taking this course understands that such person must make an independent review of medication information prior to any patient assessment, diagnosis, treatment and/or health management. Any discussion of off-label use of any medication, device, or procedure is informational only and such uses are not endorsed hereby. Nothing contained in this course represents the opinions, views, judgments, or conclusions of RxCe.com LLC. RxCe.com LLC is not liable or responsible to any person for any inaccuracy, error, or omission with respect to this course, or course material.

Computer Hardware/Software Requirements

Please ensure the device you plan to use meets these requirements and specifications:

  • Operating System: Windows 7,8,10, or 11 /Mac OS X 10.9 or later/iOS/Android
  • Supported Browsers: Microsoft Edge, Firefox, Google Chrome, Safari, Opera
  • A connection to the internet
  • For Live Webinars or Conferences: GoToWebinar application for iOS, Android, Mac, or PC. You cannot 'call into' a live conference.

  • Target Audience: Pharmacist
  • Contact Hours: 1.0 (0.1 CEUs)
  • Activity Release Date: 3/18/2023
  • Activity Expiration Date: 3/18/2026
  • Activity Type: Knowledge
  • UAN: 0669-0000-23-037-H01-P
  • Topic: Disease State Management/Drug Therapy
  • CeBroker Number: 20-1003258

Author:

L. Austin Fredrickson, MD, FACP

AUTHOR BIO

VIEW VIDEO

The logo for the Accreditation Council for Pharmacy Education (ACPE).

RxCe.com, LLC is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

‹‹ Back to Course List